Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma

计划入组 147 人 · 首次发布于 2026 年 1 月 21 日

A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours

计划入组 46 人 · 首次发布于 2021 年 5 月 17 日

A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis

计划入组 100 人 · 首次发布于 2016 年 2 月 2 日

Docetaxel(Taxotere, Docetaxel Accord, Docetaxel Kabi, Docefrez, Docetaxel Mylan)

C₄₃H₅₃NO₁₄ · Rx

Liposomal docetaxel

anbenitamab;docetaxel

Sichuan Huiyu Pharmaceutical Co., Ltd.

CRISM's ChemoSeed Platform Shows 72% Cancer Cell Kill Rate in Prostate Cancer Preclinical Studies

CRISM Therapeutics Advances Toward Phase 2 Glioblastoma Trial Despite Widening Losses

CRISM Therapeutics Advances Toward Patient Recruitment for Phase II Glioblastoma Trial of Irinotecan ChemoSeed